Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.
Also called NCT03256838
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT03256838
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT03256838. Allocation not applicable; no masking; primary purpose other. Start 2017-04-12 (actual); primary completion 2018-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
- Condition
- Kidney Failure, Chronic
- Condition
- End-stage Renal Disease
- Condition
- Phosphorus Metabolism Disorders
- Condition
- Hyperphosphatemia
- Intervention (Drug)
- Ferric Citrate
- Lead sponsor
- Panion & BF Biotech Inc.
Record details
- Record id
cardio:ct-nct03256838- Content hash
261286e94a2e16901df85e4676008bfc8f12dadb1aa1faba683d4319a63201da